Blog Profile / Reuters: Health


URL :http://uk.reuters.com/news/archive/healthNewsMolt
Filed Under:Health
Posts on Regator:2196
Posts / Week:69.7
Archived Since:August 20, 2016

Blog Post Archive

Zara founder to spend $344 million on breast cancer-screening for Spanish hospitals

7 minutes agoHealth : Reuters: Health

MADRID (Reuters) - The charitable foundation of Europe's richest man, Amancio Ortega, said on Wednesday it would spend 320 million euros ($344 million) to acquire the latest breast cancer-screening technology for public hospitals across Spain.

Singapore confirms two new cases of Zika virus

SINGAPORE (Reuters) - Singapore has confirmed two cases of locally transmitted infections of the Zika virus in a northeastern part of the city state, the National Environment Agency said on Wednesday, describing it as the first Zika cluster of 2017.

EU rapid drug approval plan worries some national agencies

3 hours agoHealth : Reuters: Health

FRANKFURT (Reuters) - A push by the European Medicines Agency to speed up the approval of new drugs that show promise is running into resistance from some of the national agencies that will ultimately decide whether the medicines are worth buying.

Meningitis outbreak in Nigeria kills 269 people

3 hours agoHealth : Reuters: Health

ABUJA (Reuters) - An outbreak of meningitis in Nigeria has killed 269 people in recent weeks, the Nigeria Centre for Disease Control said, as Africa's most populous country and aid organizations attempt to tackle the surge in infections.

FDA silence on generic Advair may be good news for GSK

6 hours agoHealth : Reuters: Health

LONDON (Reuters) - GlaxoSmithKline shares gained on Wednesday as lack of news about U.S. approval of a generic copy of its blockbuster inhaled lung drug Advair buoyed speculation that a threat to profits might be delayed.

Roche MS drug Ocrevus approved by FDA after three-month delay

13 hours agoHealth : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues.

Trump tells lawmakers he expects a deal 'very quickly' on healthcare

14 hours agoHealth : Reuters: Health

WASHINGTON (Reuters) - President Donald Trump told a group of senators on Tuesday that he expects lawmakers will be able to reach a deal on healthcare.

Brain implant lets paralyzed man feed himself using his thoughts

15 hours agoHealth : Reuters: Health

CHICAGO (Reuters) - A paralyzed man in Cleveland fed himself mashed potatoes for the first time in eight years, aided by a computer-brain interface that reads his thoughts and sends signals to move muscles in his arm, U.S. researchers said on Tuesday.

Vertex cystic fibrosis combination succeeds in late-stage trials

15 hours agoHealth : Reuters: Health

(Reuters) - Vertex Pharmaceuticals Inc said on Tuesday its Kalydeco cystic fibrosis treatment given with an experimental drug demonstrated significant improvements in lung function in a pair of late-stage trials the company plans to use to seek approval of the combination therapy.

U.S. senator launches probe into five top opioid drugmakers

17 hours agoHealth : Reuters: Health

(Reuters) - U.S. Democratic Senator Claire McCaskill sought on Tuesday details from the nation's top opioid drugmakers on their sales and marketing practices, as lawmakers step up efforts to tackle the country's deadly opioid crisis...

New budget test puts UK on front line in global drug price fight

17 hours agoHealth : Reuters: Health

LONDON (Reuters) - Can society afford modern medicines? It's a question facing governments worldwide and nowhere more so than in Britain, where a new budget test due to take effect on April 1 threatens to throw up another hurdle to patients getting the drugs.

FDA approves Regeneron, Sanofi $37,000 per year eczema drug

17 hours agoHealth : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Regeneron Pharmaceuticals Inc and Sanofi SA's drug for moderate-to-severe atopic dermatitis, a product widely seen as the most important future growth driver for the two companies.

DHA supplements during pregnancy don't raise kids' IQ

17 hours agoHealth : Reuters: Health

(Reuters Health) - Children of women who took DHA supplements during pregnancy are no smarter than peers whose mothers didn’t take the supplements, a recent study concludes.

Universal celiac testing lacks evidence - U.S. panel

17 hours agoHealth : Reuters: Health

(Reuters Health) - There is not enough evidence to encourage or discourage doctors from testing all their patients for celiac disease, according to a U.S. government-backed panel.

House Republicans consider reviving healthcare push: lawmaker

17 hours agoHealth : Reuters: Health

WASHINGTON (Reuters) - Republicans in the U.S. House of Representatives are considering a renewed push to pass legislation to repeal and replace Obamacare sometime in the next month, lawmakers and aides said on Tuesday after the collapse of the effort last week.

Delirium in critically ill children common, may go undetected

17 hours agoHealth : Reuters: Health

(Reuters Health) - About a quarter of children admitted to the intensive care unit (ICU) will develop delirium, according to the first large international study to assess how common the condition is in critically ill children.

Hong Kong lifts ban on Brazil meat imports, EU urges action

17 hours agoHealth : Reuters: Health

BRASÍLIA (Reuters) - Hong Kong said on Tuesday it has lifted a ban on the import of Brazilian meat, removing one of the last blanket bans by a major importer, but strong words from an EU commissioner visiting Brazil suggests the scandal over health standards is not over yet.

Childhood lead exposure linked to lower adult IQ

17 hours agoHealth : Reuters: Health

(Reuters Health) - Kids exposed to high levels of lead decades ago may now be approaching middle age with lower IQs and earning potential than they would have had otherwise, a new study suggests.

IVF success tied to insurance coverage

17 hours agoHealth : Reuters: Health

(Reuters Health) - Women who have insurance coverage for in vitro fertilization (IVF) may be more likely to have a baby than women who have to pay entirely out-of-pocket for fertility treatments, a U.S. study suggests.

WHO demands access to Syria's east Ghouta to bring medical aid

GENEVA (Reuters) - The health situation is deteriorating in Syria's eastern Ghouta region near Damascus, where 300,000 people are besieged and none of the three hospitals is functioning, the World Health Organization said on Monday in a call for access to deliver aid.

Copyright © 2015 Regator, LLC